EFFECT OF ERYTHROMYCIN AND TUMOR NECROSIS FACTOR ON THE DRUG-RESISTANCE OF MULTIDRUG-RESISTANT CELLS - REVERSAL OF DRUG-RESISTANCE BY ERYTHROMYCIN

被引：29

作者：

HOFSLI, E

NISSENMEYER, J

机构：

来源：

INTERNATIONAL JOURNAL OF CANCER | 1989年 / 43卷 / 03期

关键词：

D O I：

10.1002/ijc.2910430330

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：520 / 525

页数：6

共 25 条

[1]

BECK WT, 1983, CANCER TREAT REP, V67, P875

[2] CRITERIA FOR ANALYZING INTERACTIONS BETWEEN BIOLOGICALLY-ACTIVE AGENTS [J].

BERENBAUM, MC .

ADVANCES IN CANCER RESEARCH, 1981, 35 :269-335

[3]

BIEDLER JL, 1983, CANCER TREAT REP, V67, P859

[4]

CORNWELL MM, 1987, J BIOL CHEM, V262, P2166

[5]

CURT GA, 1984, CANCER TREAT REP, V68, P87

[6] ACTIVE OUTWARD TRANSPORT OF DAUNOMYCIN IN RESISTANT EHRLICH ASCITES TUMOR-CELLS [J].

DANO, K .

BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 323 (03) :466-483

[7] SPECIFICITY OF TUMOR NECROSIS FACTOR TOXICITY FOR HUMAN MAMMARY CARCINOMAS RELATIVE TO NORMAL MAMMARY EPITHELIUM AND CORRELATION WITH RESPONSE TO DOXORUBICIN [J].

DOLLBAUM, C ;

CREASEY, AA ;

DAIRKEE, SH ;

HILLER, AJ ;

RUDOLPH, AR ;

LIN, L ;

VITT, C ;

SMITH, HS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4740-4744

[8] A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES [J].

ESPEVIK, T ;

NISSENMEYER, J .

JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) :99-105

[9] MOLECULAR-BIOLOGY OF DRUG-RESISTANCE [J].

FOJO, A ;

CORNWELL, M ;

CARDARELLI, C ;

CLARK, DP ;

RICHERT, N ;

SHEN, DW ;

UEDA, K ;

WILLINGHAM, M ;

GOTTESMAN, MM ;

PASTAN, I .

BREAST CANCER RESEARCH AND TREATMENT, 1987, 9 (01) :5-16

[10]

GERLACH JH, 1986, CANCER SURV, V5, P25

← 1 2 3 →